Kenyatta University Teaching, referral and research hospital has signed a contract with the General Electric East Africa LTD., to construct an Integrated Molecular Imaging Centre (IMIC). The centre is set to be a comprehensive cancer centre and will be the first publicly owned in the country and the region.
“Today is one of the best days of my career. This is because I have had an opportunity to lead the commencement of the implementation of an idea I was part of conceptualising back when I was the Vice-Chancellor of Kenyatta University,” said Prof. Olive Mugenda the Chairperson of the board of directors.
Construction of the Integrated Molecular Imaging Center.
An Integrated Molecular Imaging Centre is a unique facility for the early diagnosis and monitoring treatment of cancer. It will cover 635 square metres located on three floors and a bunker for the cyclotron.
3D Impression of the IMIC
The IMIC project will include construction and furnishing of accommodation facilities that can host up to 100 patients who are accessing services at the centre or their members of the families.
What The Construction of the IMIC Means for Kenyans
The impact of the IMIC will be felt far and wide. Today, patients are being diagnosed with stage 3 and 4 cancers due to inadequate diagnostic capacity for early detection. The centre will have clinical, financial, training, research, socio-economic and environmental impact on Kenyans in the following areas:
- Early diagnosis and assessment of response to treatment
- Accuracy in diagnosis and treatment of cancer
- Reduction in recurrent or metastasis of cancer
- Improved survivorship
- Reduction in waiting time and cost of cancer treatment
- Significantly reduce cancer-related mortality;
- Attract medical tourism from East, West & Central Africa;
- Conserve foreign exchange used by Kenyans who seek treatment abroad;
- Support other cancer centres that invest in PET/CTs through the provision of consumables (FDGs), general support, and personnel training.